ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

24,085Medicare Part D Prescriptions Filled, Including Refills

Rank: 32 out of 676

$1.26M Total Retail Price of All Prescriptions

Rank: 27 out of 676

735 Patients Receiving at Least One Drug in Part D
66%Patients 65 Years and Older
81% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Mississippi
Lower avg

Schedule Two
Controlled Substances

18% of this provider’s 735 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

38% of this provider’s 735 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

4% of this provider’s 15,381 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

33 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Mississippi
HYDROCODONE-ACETAMINOPHEN 2,080 900 S3 1 1
FUROSEMIDE 786 604 2 4
OMEPRAZOLE 710 422 3 2
AMLODIPINE BESYLATE 709 485 4 3
LEVOTHYROXINE SODIUM 550 430 5 7
LISINOPRIL 542 362 6 5
FENTANYL 475 204 S2 7 93
GABAPENTIN 402 291 8 10
POTASSIUM CHLORIDE 361 280 9 9
TRAZODONE HCL 353 272 10 36
NAMENDA 329 326 11 35
WARFARIN SODIUM 327 246 12 18
DONEPEZIL HCL 315 300 13 24
MELOXICAM 304 200 14 13
SIMVASTATIN 292 216 15 6
RANITIDINE HCL 253 216 16 27
METOPROLOL SUCCINATE 250 178 17 14
METFORMIN HCL 237 119 18 8
FLUOXETINE HCL 233 145 19 70
ATENOLOL 218 165 20 25
GLIMEPIRIDE 213 164 21 30
SERTRALINE HCL 206 155 22 26
ZOLPIDEM TARTRATE 202 64 23 21
AMLODIPINE BESYLATE-BENAZEPRIL 201 133 24 44
ALLOPURINOL 200 141 25 31
TRAMADOL HCL 194 126 26 19
ATORVASTATIN CALCIUM 191 122 27 20
CARVEDILOL 188 115 28 15
AMPHETAMINE SALT COMBO 188 21 S2 28 245
HYDROCHLOROTHIAZIDE 178 104 30 12
METHADONE HCL 178 25 S2 30 282
CLONIDINE HCL 177 105 32 32
AZITHROMYCIN 176 119 33 39
LISINOPRIL-HYDROCHLOROTHIAZIDE 168 65 34 16
BENZTROPINE MESYLATE 156 108 R 35 129
PRAVASTATIN SODIUM 149 106 36 11
CYMBALTA 145 65 37 47
PANTOPRAZOLE SODIUM 143 94 38 42
QUETIAPINE FUMARATE 141 118 39 72
TAMSULOSIN HCL 141 118 39 38
POLYETHYLENE GLYCOL 3350 139 97 41 56
MIRTAZAPINE 138 120 42 59
CARISOPRODOL 129 11 R 43 60
PROMETHAZINE HCL 128 46 R 44 75
PHENYTOIN SODIUM EXTENDED 126 85 45 88
DIOVAN 126 89 45 37
CRESTOR 124 79 47 29
DILTIAZEM ER 123 90 48 118
DIGOXIN 122 114 49 52
LYRICA 122 33 49 57
MORPHINE SULFATE ER 122 28 S2 49 131
METOPROLOL TARTRATE 118 84 52 22
CLOPIDOGREL 109 92 53 28
PREDNISONE 109 104 53 53
AMITRIPTYLINE HCL 108 65 R 55 46
ISOSORBIDE MONONITRATE ER 107 90 56 54
HUMALOG 105 89 57 230
CARBIDOPA-LEVODOPA 103 97 58 114
GLIPIZIDE 103 68 58 81
EXFORGE 102 54 60 132
DIVALPROEX SODIUM 101 52 61 99
CITALOPRAM HBR 97 73 62 17
TOPIRAMATE 95 18 63 141
VENLAFAXINE HCL ER 92 66 64 98
CYCLOBENZAPRINE HCL 92 35 R 64 50
DIOVAN HCT 91 70 66 41
GLYBURIDE-METFORMIN HCL 90 42 R 67 76
LEVEMIR 86 59 68 157
SINGULAIR 85 66 69 80
BUPROPION XL 84 31 70 227
ROPINIROLE HCL 81 57 71 85
ADVAIR DISKUS 81 67 71 87
BACLOFEN 81 50 71 144
ENDOCET 81 0 S2 71 104
HYDRALAZINE HCL 80 70 75 77
LACTULOSE 80 75 75 110
PROAIR HFA 78 42 77 79
OXYCODONE HCL-ACETAMINOPHEN 75 35 S2 78 139
TIZANIDINE HCL 74 14 79 68
MONTELUKAST SODIUM 73 53 80 150
DEXAMETHASONE 73 47 80 270
NITROFURANTOIN MONO-MACRO 72 66 82 182
PLAVIX 72 68 82 40
NEXIUM 72 24 82 23
CIPROFLOXACIN HCL 70 60 85 45
LOVASTATIN 69 35 86 33
ESTRADIOL 69 0 R 86 109
FLUTICASONE PROPIONATE 68 50 88 49
SEROQUEL 67 54 89 135
DILTIAZEM 24HR CD 67 36 89 152
LOSARTAN POTASSIUM 67 46 89 34
ABILIFY 65 14 92 133
OXYCODONE HCL 64 40 S2 93 165
LANTUS 64 41 93 55
NIFEDIPINE ER 63 29 95 100
KLOR-CON M20 63 63 95 67
SUBOXONE 61 17 97 173
PAROXETINE HCL 60 42 98 65
NAPROXEN 59 22 99 71
FENOFIBRATE 57 28 100 90
BENAZEPRIL HCL 56 42 101 58
NYSTATIN 55 34 102 198
THEOPHYLLINE ANHYDROUS 55 43 102 261
SPIRONOLACTONE 55 43 102 62
EXELON 53 49 105 130
KLOR-CON M10 52 52 106 195
TRIAMCINOLONE ACETONIDE 52 29 106 191
TRILIPIX 51 16 108 232
GLYBURIDE 51 28 R 108 92
FAMOTIDINE 51 34 108 64
DOXYCYCLINE HYCLATE 50 37 111 82
SAVELLA 50 0 111 340
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 6, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.